Literature DB >> 21651593

Correlation between AF substrate ablation difficulty and left atrial fibrosis quantified by delayed-enhancement cardiac magnetic resonance.

Julien Seitz1, Jérôme Horvilleur, Jérôme Lacotte, Darach O H-Ici, Yamina Mouhoub, Alice Maltret, Fiorella Salerno, Darren Mylotte, Mehran Monchi, Jérôme Garot.   

Abstract

BACKGROUND: Studies have shown that the presence of left atrial (LA) fibrosis can be assessed by LA delayed-enhancement cardiac magnetic resonance (LA DE-CMR) and may be predictive of outcome after ablation for atrial fibrillation (AF). We sought to test the hypothesis that the amount of LA fibrosis evaluated by DE-CMR correlates with the difficulty of complex fractionated atrial electrograms (CFAE) ablation.
METHODS: Twenty-two consecutive patients (86.4% nonparoxysmal AF) underwent substrate CFAE radiofrequency (RF) ablation (±Pulmonary veins isolation) with AF termination as the endpoint. LA DE-CMR was performed prior to ablation. A global index of DE was defined by an average of six LA segmental scores based on a four-grade scale (no enhancement to maximum enhancement). Time between first RF application and AF termination, and RF duration until AF termination, was recorded. CFAE area/total LA surface was also measured on CARTO maps (Biosense Webster, Diamond Bar, CA, USA). These measures served to evaluate ablation difficulty, and were correlated with CMR images by double-blinded analysis.
RESULTS: Ablation restored sinus rhythm in 20 of 22 patients (91%), with a time to terminate AF of 140 ± 91 minutes. There was a significant correlation between the global averaged DE-CMR fibrosis grade and the electrophysiological substrate indexes such as "time to terminate AF" (Rho = 0.70, P = 0.0003), "RF duration until AF termination" (Rho = 0.65, P = 0.001), and a trend toward correlation with "CFAE area/LA surface" (Rho = 0.47, P = 0.03).
CONCLUSIONS: LA DE-CMR can predict increased difficulty of CFAE ablation in AF. This tool may be beneficial in both selection of patients and ablation strategy. ©2011, The Authors. Journal compilation ©2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651593     DOI: 10.1111/j.1540-8159.2011.03148.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

Review 1.  Differences of BiAtrial Substrate Properties in Patients with Different Types of AF.

Authors:  Kazuyoshi Suenari; Hidekazu Hirao; Mitsunori Okamoto; Yasuki Kihara; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 2.  Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Authors:  Zhenghong Wu; Yunlong Liu; Lv Tong; Diandian Dong; Dongdong Deng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

Review 3.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 4.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

Review 5.  Role of cardiac computed tomography and cardiovascular magnetic resonance imaging in guiding management and treatment of patients with atrial fibrillation: state of the art review.

Authors:  Wael A Aljaroudi; Walid S Saliba; Oussama M Wazni; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2013-02-12       Impact factor: 5.952

Review 6.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

Review 7.  Left Atrium: Still a Neglected Chamber?

Authors:  Maria Chiara Todaro; Bijoy K Khandheria
Journal:  J Cardiovasc Echogr       Date:  2014 Jul-Sep

Review 8.  Multimodality Imaging for Atrial Fibrosis Detection in the Era of Precision Medicine.

Authors:  Valentina Barletta; Lorenzo Mazzocchetti; Matteo Parollo; Davide Spatafora; Maria Grazia Bongiorni; Giulio Zucchelli
Journal:  J Cardiovasc Echogr       Date:  2022-01-24

9.  Methodology for patient-specific modeling of atrial fibrosis as a substrate for atrial fibrillation.

Authors:  Kathleen S McDowell; Fijoy Vadakkumpadan; Robert Blake; Joshua Blauer; Gernot Plank; Rob S MacLeod; Natalia A Trayanova
Journal:  J Electrocardiol       Date:  2012-09-19       Impact factor: 1.438

Review 10.  Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways.

Authors:  Muhammad A Balouch; Matthew J Kolek; Dawood Darbar
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.